Immune Response News and Research

RSS

Blame your genes: why some people get sicker for longer

People with certain high risk gene combinations are eight times more likely to suffer from a severe and prolonged illness when they have an infection, according to University of New South Wales (UNSW) researchers.

1 Dec 2008

Genes influence how well you deal with an illness

Australian scientists have discovered that a person's genetic makeup can influence how they are affected by illness - they say a certain genetic vulnerability can amplify an illness.

1 Dec 2008

Research identifies cell receptor as target for anti-inflammatory immune response

Cell reception. By comparing normal mice (left) with mice that are genetically engineered to lack certain receptors in their spleen (right), scientists have shown SIGNR1 receptors (blue) are required to facilitate an anti-inflammatory action.

28 Nov 2008

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Peregrine Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number No. 7,455,833, which includes broad claims covering anti-viral applications of antibodies that directly bind to aminophospholipids.

25 Nov 2008

New vaccine principle delivers stronger and faster immune response

A new vaccine principle is being developed by scientists at the University of Copenhagen which - if it works to its full expected potential - could help to save millions of lives and revolutionise current vaccine technology.

24 Nov 2008

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Medarex, Inc. has announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody for the treatment of cancer.

24 Nov 2008

Humoral immunity in kidney transplantation

There are more than 76,000 end-stage renal disease patients waiting for one of the 17,000 kidneys transplanted each year, making a host rejection an unacceptable waste.

24 Nov 2008

Viral Genetics completes acquisition of V-Clip Pharmaceuticals

Viral Genetics, Inc. has announced it has completed its acquisition of V-Clip Pharmaceuticals, Inc. ("V-Clip").

19 Nov 2008

Vaccine-related chronic fatigue syndrome in an individual demonstrating aluminium overload

A team of scientists have investigated a case of vaccine-associated chronic fatigue syndrome (CFS) and macrophagic myofasciitis in an individual demonstrating aluminium overload.

18 Nov 2008

Scientists discover new cause of fatal brain injury from acute viral meningitis

In a November 16 advance, online publication of the journal Nature, the researchers say their discovery revamps common beliefs about how such potentially lethal infections may be ravaging the brain and suggests the possibility of new treatments.

17 Nov 2008

Blood exosomes shown to contain tumor-specific genetic information for brain cancer

Tiny vesicles called exosomes released into the bloodstream from aggressive brain tumors contain genetic signatures that may help guide future diagnosis and treatment of this deadly disease.

17 Nov 2008

Microvesicles released from glioblastoma cells carry information that may guide treatment

Microvesicles - tiny membrane-covered sacs - released from glioblastoma cells contain molecules that may provide data that can guide treatment of the deadly brain tumor.

16 Nov 2008

Plastic surgeons warn of malnutrition in body contouring patients

Identifying malnutrition before surgery in massive weight loss patients seeking body contouring will significantly decrease surgical complications, accelerate wound healing, improve scar quality and boost patient energy levels, according to a study in the December issue of Plastic and Reconstructive Surgery ®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

16 Nov 2008

Gene chip technology used to rapidly and accurately detect pneumonia in ICU Patients on ventilators

Even seasoned doctors have a difficult time diagnosing pneumonia in hospitalized patients breathing with the assistance of a ventilator.

16 Nov 2008

Analyses of Merck's HIV vaccine 'Step' study

Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online in two papers in The Lancet.

12 Nov 2008

Breakthrough in rheumatoid arthritis research

Rheumatoid arthritis is a painful, inflammatory type of arthritis that occurs when the body's immune system attacks itself.

12 Nov 2008

New report shows high Clostridium difficile infection rates in U.S. hospitals

Consumers Union called on hospitals today to take more aggressive steps to protect patients from Clostridium difficile (C.-diff.) infections in light of a new report showing that they are much more common than previous estimates had indicated. As the rate of hospital acquired C.-diff. infections has jumped in recent years, an increasing number of patients have developed antibiotic-resistant strains of the infection that are more difficult to treat and more deadly.

11 Nov 2008

T-cell-based strategy for HIV-1 vaccines still viable option

The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520.

10 Nov 2008

Scientists engineer immune cells to act as "bionic assassins" that see through HIV's many disguises

HIV is a master of disguise, able to rapidly change its identity and hide undetected in infected cells.

10 Nov 2008

Scientists engineer T cells to recognize HIV-1 strains that have evaded the immune system

The findings of the study, published online in the journal Nature Medicine, have important implications for developing new treatments for HIV, especially for patients with chronic infection who fail to respond to antiretroviral regimens.

10 Nov 2008

Immune Response News and Research

Blame your genes: why some people get sicker for longer

Genes influence how well you deal with an illness

Research identifies cell receptor as target for anti-inflammatory immune response

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

New vaccine principle delivers stronger and faster immune response

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Humoral immunity in kidney transplantation

Viral Genetics completes acquisition of V-Clip Pharmaceuticals

Vaccine-related chronic fatigue syndrome in an individual demonstrating aluminium overload

Scientists discover new cause of fatal brain injury from acute viral meningitis

Blood exosomes shown to contain tumor-specific genetic information for brain cancer

Microvesicles released from glioblastoma cells carry information that may guide treatment

Plastic surgeons warn of malnutrition in body contouring patients

Gene chip technology used to rapidly and accurately detect pneumonia in ICU Patients on ventilators

Analyses of Merck's HIV vaccine 'Step' study

Breakthrough in rheumatoid arthritis research

New report shows high Clostridium difficile infection rates in U.S. hospitals

T-cell-based strategy for HIV-1 vaccines still viable option

Scientists engineer immune cells to act as "bionic assassins" that see through HIV's many disguises

Scientists engineer T cells to recognize HIV-1 strains that have evaded the immune system

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News